Justia Products Liability Opinion Summaries

A patient underwent surgery in Texas, during which a specific surgical stapler and staple product were used to reconnect sections of his colon. After initial success, he suffered severe complications days later, including sepsis, allegedly caused by a defect in the staple line. This resulted in months of treatment and ultimately his death. His widow and children sued several product manufacturers and sellers, asserting claims for breach of implied warranty of merchantability and other product liability theories.Initially, the plaintiffs brought suit in the United States District Court for the Western District of Texas against Johnson & Johnson, Ethicon, and Ethicon Endo-Surgery, Inc. (“Phillips I”). Discovery revealed confusion about the identity of the actual seller, prompting the plaintiffs to file an amended complaint against Ethicon Endo-Surgery, Inc. alone, asserting only breach of warranty claims. The magistrate judge recommended dismissing the claim for breach of implied warranty of merchantability without prejudice, primarily due to lack of presuit notice required under Texas law. The district court instead dismissed both claims with prejudice and denied leave to amend, finding that amendment would be futile and that the plaintiffs had not provided proper notice or shown how they could cure the defect.After dismissal in Phillips I, the plaintiffs filed a second suit in state court (“Phillips II”) against additional parties. This case was removed to federal court, where the defendants moved for dismissal based on res judicata and collateral estoppel. The district court adopted the magistrate judge’s recommendation and dismissed Phillips II with prejudice. On appeal, the United States Court of Appeals for the Fifth Circuit affirmed both district court judgments, holding that plaintiffs failed to state a claim due to lack of presuit notice, the denial of leave to amend was not an abuse of discretion, and preclusion doctrines properly barred the second suit. View "Phillips v. Ethicon Endo-Surgery" on Justia Law

The plaintiffs purchased a residential lot from a developer and later alleged that defective grading and drainage in the subdivision caused water and erosion damage to their property. They claimed that the developer and seller deviated from an approved drainage plan, redirecting stormwater onto their lot. The plaintiffs discovered the source of the problem several years after purchasing the property, following a heavy rainstorm. Their claims included negligence, breach of contract, and breach of the implied warranty of workmanlike construction.The District Court of Oklahoma County conducted a bench trial. After the plaintiffs rested their case, the defendants moved for a directed verdict and argued that the tort and warranty claims were barred by Oklahoma’s ten-year statute of repose (12 O.S. § 109), and the contract claim was barred by the five-year statute of limitations (12 O.S. § 95). The trial court found that the improvement causing the harm was substantially completed more than ten years before suit, and that the contract claim accrued on the date the lot was conveyed. The trial court entered judgment for the defendants on all claims.The Supreme Court of the State of Oklahoma reviewed the appeal. It held that the statute of repose begins to run upon substantial completion of the specific improvement alleged to have caused harm, not the completion of the overall development. The only evidence of substantial completion was uncontroverted, showing completion more than ten years before suit, barring the tort claims. The implied warranty and contract claims were also time-barred by the statute of limitations, and Turner & Company was not a party to the contract. The judgment of the District Court was affirmed. View "ESCH v. TURNER & COMPANY, INC." on Justia Law

Insurance companies paid claims to policyholders whose Hyundai or Kia vehicles were stolen or damaged due to a vulnerability stemming from the lack of an engine immobilizer in certain models from 2011 to 2022. These companies, as subrogees, filed a nationwide class action alleging that the Korean manufacturers, Hyundai Motor Company and Kia Corporation, defectively designed these vehicles, making them prone to theft. The complaint also asserted claims for breach of warranties, violations of consumer protection statutes, fraud, unjust enrichment, and negligent failure to warn.Multiple lawsuits arising from this issue were consolidated into multidistrict litigation before the United States District Court for the Central District of California. The district court dismissed the claims against the Korean entities for lack of personal jurisdiction, concluding that the evidence did not establish intentional targeting of California by the manufacturers and that the claims did not arise from California-related conduct. The district court also denied leave to amend and jurisdictional discovery, entering final judgment under Rule 54(b) dismissing the Korean entities from the subrogation track.On appeal, the United States Court of Appeals for the Ninth Circuit reviewed the district court’s dismissal de novo. The Ninth Circuit held that the Korean manufacturers were subject to specific personal jurisdiction in California. The panel found that the manufacturers purposefully directed their activities toward California by sending thousands of shipments of vehicles through California ports and designing vehicles specifically for the U.S. market. The court further held that the claims arose out of these California contacts, as the injuries were caused by vehicles shipped to California. The panel reversed the district court’s dismissal and remanded the case for further proceedings, leaving the question of reasonableness of jurisdiction for the district court to resolve. View "IN RE: KIA HYUNDAI VEHICLE THEFT MARKETING, SALES PRACTICES, AND PRODUCTS LIABILITY LITIGATION" on Justia Law

Several counties and municipalities in New York initiated lawsuits in state courts against two pharmacy benefit managers, Express Scripts, Inc. and OptumRx, Inc., alleging that these companies contributed to the opioid epidemic in their communities. The claims are based on state law and center on the defendants’ alleged practices in negotiating with opioid manufacturers and managing prescription formularies, which plaintiffs contend led to an oversupply of prescription opioids and caused substantial public harm and government expense.The defendants removed the cases to federal court—the United States District Courts for the Southern and Eastern Districts of New York—arguing removal was proper under the federal officer removal statute, 28 U.S.C. § 1442(a)(1), because some of the challenged conduct was performed under contracts with federal agencies, such as the Department of Defense (TRICARE), the Office of Personnel Management (FEHBP), and the Veterans Health Administration. After removal, the plaintiffs amended their complaints to disclaim any claims based on the defendants’ work for federal clients, seeking to have the cases remanded to state court. The district courts accepted the disclaimers and remanded the cases.The United States Court of Appeals for the Second Circuit reviewed the district courts’ decisions. It concluded that the disclaimers were ineffective because the alleged wrongful conduct and resulting harms could not be separated between federal and non-federal clients; the conduct was indivisible. Relying on the Supreme Court's decision in Chevron USA Inc. v. Plaquemines Parish, the Second Circuit held that the defendants satisfied all statutory requirements for federal officer removal: they acted under federal direction, were sued for acts relating to federal authority, and asserted colorable federal defenses. The Second Circuit therefore reversed the remand orders and returned the cases to the district courts for further proceedings. View "County of Westchester v. Express Scripts" on Justia Law

A fatal car accident involving an eighteen-year-old driving a 2013 Toyota Scion led to a lawsuit by the driver’s estate against Toyota and Subaru, who had jointly developed the vehicle. The plaintiff alleged negligence, product liability, and violations of North Carolina’s Unfair and Deceptive Trade Practices Act, claiming that design defects caused the occupant compartment to collapse and a fire to spread, ultimately resulting in the driver’s death. During discovery, the plaintiff requested extensive documents and depositions, including English translations of Japanese-language materials. Toyota and Subaru objected to several document requests and deposition topics, and disputes arose regarding the timing and sufficiency of their responses.The Superior Court of Robeson County granted the plaintiff’s motions to compel, ordered the production of additional documents (including English translations), and mandated that Toyota and Subaru’s corporate representatives testify to all noticed deposition topics without further objection. When the defendants failed to comply as ordered, the trial court imposed sanctions, deeming certain facts established against them—including elements of duty and breach in the plaintiff’s product liability claim—and struck their regulatory compliance defense. Toyota and Subaru appealed, challenging the discovery and sanctions orders.The North Carolina Court of Appeals vacated the sanctions order and reversed the requirement to translate documents but otherwise affirmed the discovery order, holding that most of the trial court’s actions were not an abuse of discretion. The Supreme Court of North Carolina reviewed only the remaining issues in the discovery order. It held that the trial court erred by enforcing a fourteen-day deadline for objections to document requests in deposition notices (rather than the seven days required by the rules), and by waiving defendants’ objections to deposition topics for not seeking a protective order. Accordingly, the Supreme Court reversed the relevant portions of the Court of Appeals’ decision, instructed it to vacate the discovery order, and remanded for further proceedings. View "Sessoms v. Toyota Motor Sales, U.S.A., Inc" on Justia Law

A worker was severely injured while operating a piece of agricultural machinery at his place of employment. The machine’s power take-off (PTO) shaft, which should have been equipped with safety guards, lacked those guards at the time of the accident. The worker alleged that the absence of these safety guards was due to his employer’s deliberate removal, and that this action directly caused his injuries. He sued his employer for an intentional tort under Ohio law, specifically invoking a statutory provision that creates a rebuttable presumption of intent to injure when an employer deliberately removes an equipment safety guard and an injury results.The Madison County Court of Common Pleas denied the employer’s motion for summary judgment, finding a genuine dispute of material fact as to whether the employer had deliberately removed the safety guard. The case proceeded to trial, where the jury heard evidence about the condition of the machinery, the employer’s repair practices, and the employer’s responses to safety concerns. The jury found in favor of the worker, awarding significant compensatory damages for his injuries. On appeal, the Twelfth District Court of Appeals reversed, holding that the evidence did not support a finding of deliberate removal as a matter of law, and that the statutory presumption did not apply unless the employer both removed the guard and made a conscious decision not to replace it.The Supreme Court of Ohio reversed the judgment of the court of appeals. It held that when reviewing the denial of summary judgment after a trial, appellate courts must consider the full trial record, not just the pretrial record. The court further held that the statutory presumption applies when there is evidence of deliberate removal of a safety guard, and that courts may not require proof of a separate, additional decision not to replace the guard. The case was remanded for further proceedings consistent with this holding. View "Camara v. Gill Dairy, L.L.C." on Justia Law

After the death of their fourteen-year-old daughter Taylor Rose Sookra in December 2021, four months after she received Pfizer’s COVID-19 vaccine, Arthur Sookra and April Burch-Sookra filed a lawsuit. They alleged willful misconduct under the Public Readiness and Emergency Preparedness Act (PREP Act) against Pfizer, federal officials, the physician who administered the vaccine, and the pediatric practice. Their claims included both federal law claims and state-law tort claims.Initially, the case was filed in the United States District Court for the Eastern District of New York. When the Sookras added a PREP Act willful-misconduct claim, they requested and obtained a transfer to the United States District Court for the District of Columbia, as required by the statute. The defendants moved to dismiss, and the motions were referred to a magistrate judge who recommended dismissal of the claims against the federal government on sovereign immunity grounds and against Pfizer for failure to exhaust administrative remedies. The magistrate also recommended dismissal of Pfizer’s state-law claims based on immunity and advised that the court decline supplemental jurisdiction over the remaining state-law claims. The district court adopted these recommendations, dismissed the case, and denied as moot the plaintiffs’ later request for a three-judge court.On appeal, the United States Court of Appeals for the District of Columbia Circuit held that the district court erred by dismissing the complaint without first convening a three-judge court, as required by 42 U.S.C. § 247d-6d(e)(5) for willful-misconduct claims under the PREP Act. The appellate court vacated the district court’s judgment and remanded with instructions to initiate procedures for convening a three-judge court. The court did not address the other arguments raised by the parties. View "Sookra v. Pfizer Inc." on Justia Law

Several parents whose premature infants developed necrotizing enterocolitis (NEC) after being fed cow’s milk-based formula at Pennsylvania Hospital sued the manufacturers of the formula, as well as the hospital, in Pennsylvania state court. The parents alleged that the manufacturers’ products caused NEC and that the hospital failed to warn of the risks and implement policies to protect patients. Some plaintiffs were Pennsylvania citizens and others from New Jersey. The hospital and its related entities were named as defendants, and the claims against them were based on state law.After the lawsuits were filed, the manufacturers removed the cases to federal court. The United States District Court for the Eastern District of Pennsylvania transferred the cases to a multidistrict litigation proceeding in the Northern District of Illinois. The plaintiffs’ initial motion to remand was granted after the district court found that the claims against the hospital were potentially viable, defeating removal on diversity grounds. The cases returned to Pennsylvania state court, where discovery proceeded and the hospital was later dismissed with prejudice after the state court sustained preliminary objections. The plaintiffs did not immediately appeal. The manufacturers then removed the cases a second time, arguing that the hospital had been fraudulently joined solely to defeat diversity jurisdiction. The district court denied the plaintiffs’ motion to remand, this time concluding that the plaintiffs’ lack of active pursuit of claims against the hospital showed “no real intention in good faith to prosecute the action,” amounting to fraudulent joinder.On interlocutory appeal, the United States Court of Appeals for the Seventh Circuit reversed. The Seventh Circuit held that fraudulent joinder exists only where a plaintiff makes false jurisdictional allegations or has no chance of success against the non-diverse defendant, taking all facts and law in the plaintiff’s favor. The court held that the plaintiffs’ litigation conduct and subjective intent are not proper bases for finding fraudulent joinder. The case was remanded for further proceedings. View "Abdullah v Mead Johnson & Company LLC" on Justia Law

A group of plaintiffs, represented by the same counsel as earlier litigants, alleged injuries caused by cellphone radiation exposure. Their complaints were nearly identical to those in a previous set of cases involving similar claims. The plaintiffs agreed, through joint stipulations filed in their cases, that the outcome of expert admissibility litigation in the earlier cases would apply to their own. This agreement included being bound by both the substantive ruling on whether expert testimony about general causation was admissible and all procedural rulings leading up to that determination. The stipulations were signed by counsel for both sides, and subsequent court orders stayed the plaintiffs’ cases pending the resolution of expert admissibility in the earlier litigation.The Superior Court of the District of Columbia managed the earlier cases by first resolving whether the plaintiffs had admissible expert testimony on general causation, limiting discovery to that issue. After several hearings and rulings, the court ultimately excluded the plaintiffs’ expert testimony under the Daubert/Rule 702 standard, and granted summary judgment to the defendants because the plaintiffs lacked the necessary expert evidence to support their claims. The Brooks plaintiffs later moved to lift the stays in their cases, arguing for broader discovery and the opportunity to present new expert witnesses, but the court denied this motion.The District of Columbia Court of Appeals reviewed whether the Brooks plaintiffs were bound by their agreements and the trial court’s rulings. The court held that the plaintiffs had agreed—expressly or implicitly—to be bound by both the outcome of the expert admissibility litigation and the procedural rulings in the earlier cases. The court affirmed the Superior Court’s grant of summary judgment to the defendants, holding that the plaintiffs lacked admissible expert testimony required to prove their claims. View "Brooks v. Mitsubishi Electric & Electronics US, Inc." on Justia Law

A mother brought suit on behalf of herself and her minor son, alleging that the son developed leukemia after attending school near and residing close to a manufacturing plant operated by General Electric Company. The plant, located in Pittsfield, Massachusetts, produced electrical transformers and capacitors containing polychlorinated biphenyls (PCBs) for decades. The plaintiff claimed that GE’s use, disposal, and storage of PCBs caused the son’s illness, and sought recovery under various legal theories, including strict liability, negligence, fraudulent misrepresentation, nuisance, improper transportation of hazardous material, and loss of consortium. The complaint included claims related to the defective design and use of PCB materials, as well as their disposal and remediation.The plaintiff originally filed suit in Massachusetts state superior court. GE removed the case to the United States District Court for the District of Massachusetts, asserting federal officer removal jurisdiction under 28 U.S.C. § 1442(a)(1), based on its wartime production of PCB-containing devices for the federal government and its later remediation efforts pursuant to a consent decree with the EPA. The plaintiff moved to remand the case to state court, arguing that GE failed to meet the requirements for federal officer removal. The district court agreed, ordered remand, and stayed that order pending appeal.The United States Court of Appeals for the First Circuit reviewed the district court’s jurisdictional determination de novo. It held that GE satisfied both the “acting under” and “for or relating to” elements of the federal officer removal statute, due to its extensive work producing PCB-containing devices for the federal government. The court reversed the district court’s remand order and remanded the case for the district court to determine whether GE has a colorable federal defense. View "Czerno v. General Electric Company" on Justia Law